Table 4.

COVID-19 infection after study enrollment.

Variable	Received Evusheld (n = 43)	Did Not Receive Evusheld (n = 30)	p
Total COVID infections (asymptomatic and symptomatic)	10 (23.3)	6 (20)	0.59
1. Asymptomatic SARS-CoV-2 infection	4 (9.3)	0	0.42
2. Symptomatic COVID-19 disease	6 (14)	6 (20)	0.63
3. COVID-19 related hospitalization	6 (14)	6 (20)	0.63
4. ICU admission for COVID-19	0	6 (20)	0.033 *
5. COVID-19 related death	0	3 (10)	0.036 *

* p < 0.05.